Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation: 07/12/2023, Revision: 6, Status: Authorised
Agenda - PDCO agenda of the 21-24 April 2026 meeting
Human medicines European public assessment report (EPAR): Arsenic trioxide medac, arsenic trioxide, Date of authorisation: 17/09/2020, Revision: 3, Status: Authorised
Herbal medicinal product: Centaurii herba, Centaurium erythraea Rafn. s.l., C: ongoing call for scientific data
Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Ferriprox, deferiprone, Date of authorisation: 25/08/1999, Revision: 34, Status: Authorised
Process for the electronic submission of medicinal product information - Chapter 3
Process for submitting existing data on medicinal products authorised for human use – SIAMED II & XEVMPD to PMS deltas - Chapter 9
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - March 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 March 2026, 15:00 (CET) to 12 March 2026, 16:00 (CET)